TC2N transcription was significantly higher in cholangiocarcinoma (CHOL), ovarian serous cystadenocarcinoma (OV), rectal adenocarcinoma (READ), stomach adenocarcinoma (STAD) and thymoma (THYM) (Figure 1A, Figure 1B). Here, TC2N is linked to ovarian serous cystadenocarcinoma.